CLINICAL_TRIALS
trial_result
· 2019-09-30
Clinical Trial Update: Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation [Phase 4]
Summary
Phase 4 trial investigating liraglutide effects on liver glucose phosphorylation, status withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cedars-Sinai Medical Center | Conditions: Type 2 Diabetes | Phase 4 | Status: WITHDRAWN